DateTitle
05/14/08Hythiam Announces Presentation at Rodman & Renshaw 5th Annual Global Healthcare Conference in Monaco
05/12/08Hythiam Announces First Quarter Results
05/06/08Hythiam Announces Commercial Reimbursement with National Third-Party Payor
05/06/08Hythiam to Announce First Quarter Results on Monday, May 12Th
03/17/08Hythiam Announces Fourth Quarter and 2007 Year-End Results
03/14/08Pilot Program Involving Prometa Treatment Program and Standard of Care Demonstrates Improved Outcomes in Methamphetamine Dependent, Medicaid Eligible Participants in Arizona
03/10/08Hythiam to Announce Fourth Quarter and Fiscal 2007 Year-End Results on Monday, March 17th
02/12/08Hythiam Announces Presentation at the Roth 20th Annual OC Growth Stock Conference
02/05/08Hythiam Announces Presentation at UBS Global Healthcare Services Conference
02/04/08Hythiam Announces First Commercial Reimbursement Agreements with Third-Party Payors
01/30/08Ian Worden Joins Hythiam as Senior Vice President, Disease Management Operations
01/10/08U.S. Patent Office Allows Hythiam Patent Application Underlying the PROMETA Treatment Program for Alcoholism
01/07/08Hythiam Provides Corporate Update to Shareholders
12/10/07Hythiam's PROMETA(R) Treatment Program Featured on CBS's 60 Minutes on Sunday Night
12/07/07Hythiam's PROMETA(R) Treatment Program to Be Featured on ABC's Nightline This Evening and CBS's 60 Minutes on Sunday
12/06/07Hythiam, Inc. to Present at RBC Capital Markets 2007 Healthcare Conference
12/04/07Hythiam Comments on Recent Trading Activity
12/03/07PROMETA Treated Patient Subject of MTV's True Life Reality Show
11/08/07Hythiam Announces Record Third Quarter Results
11/07/07Hythiam to Announce Third Quarter Results on Thursday, November 8th
11/07/07Hythiam, Inc. Raises Approximately $46 Million in Equity Offering
11/05/07Russian Patent Office Provides Notification of Intention to Grant Hythiam Patent for Treatment of Cocaine Dependence
11/01/07Hythiam's PROMETA(R) Treatment Program Demonstrates Statistically Significant Reduction in Methamphetamine Cravings in Randomized, Double-Blind Placebo-Controlled Study
10/31/07Hythiam to Announce Urschel Double-Blind Placebo-Controlled Study Results on Thursday, November 1st
10/03/07Hythiam and The Assist Group to Collaborate on Post-Delivery Disease Management Program for Substance Dependent Mothers on Medicaid
10/01/07Investigators Observe Significant Reduction in Methamphetamine Cravings and Use in Study of Component of Hythiam's PROMETA Treatment Program Published in Mayo Clinic Proceedings Journal
09/27/07Hythiam, Inc. to Present at William Blair & Company's Small-Cap Growth Stock Conference
09/19/07Hythiam, Inc. to Present at the 2007 UBS Global Life Sciences Conference
09/17/07Collin County, Texas Adopts Hythiam's PROMETA(R) Treatment Program
09/12/07Hythiam, Inc. to Present at the Fourth Annual Merriman Curhan Ford & Co. Investor Summit
09/11/07Hythiam Announces City of Las Vegas Municipal Drug Court to Implement PROMETA(R) Treatment Program
09/05/07Denton County, Texas to Implement and Fund Hythiam's First County Level PROMETA(R) Treatment Program for Substance Dependence Among Probationees
08/29/07Hythiam, Inc. to Present at the Roth Capital Partners New York Conference
08/27/07Hythiam Launches Online Recovery Media Network in Advance of Recovery Month in September
08/21/07Leading Panamanian Hospital Centro Medico Paitilla to Serve as Hythiam's Initial PROMETA Licensee for Central and South America
08/14/07Hythiam, Inc. to Present at the Noble Financial Two Double-0-Seven Small Cap Equity Conference
08/09/07Hythiam Announces Second Quarter Results
07/31/07Hythiam to Announce Second Quarter Results on Thursday, August 9th
07/10/07Hythiam Appoints Past Indiana State Attorney General and Former Head of National Drug Court Institute to Board of Directors
06/20/07Texas Governor Signs Budget into Law Including $2 Million That Can Be Used to Fund PROMETA(R) Treatment Programs for Criminal Justice Program
06/14/07Hythiam Schedules Corporate Update Webcast from Annual Meeting of Stockholders
06/07/07Hythiam Secures Patents Underlying PROMETA Treatment Protocols in China and Korea
06/06/07Hythiam Included in Top 100 Most Trustworthy Companies in America
05/29/07Hythiam and CompCare Terminate Merger Agreement